Dr. Townson heads development programs for Immuno-oncology and Cell Therapy assets at Bayer.
Dr. Townson’s current development activities include: AhR-inhibition, DGK-inhibition, and allogeneic CAR-T treatment. In the past several years Dr. Townson’s successes include the global registration and launch of hematology and cell therapy assets as well as multiple INDs and early clinical testing of novel small-molecule and anti-body check-point therapies.
Arena’s business-to-business events offer a myriad of opportunities for sponsors and exhibitors to drive their businesses forward.
Our sponsorship packages help companies educate ther target market on key industry issues and spread brand awareness throughout the
If you want to discuss how we can help you generate leads and add-value to your corporate and brand image please contact:
+44 (0)20 7936 6948